Summary
Clonidine, 0.1 mg/kg i.p., or saline was administered to mice twice daily for 12 days. After withdrawal of the drug (14–18.5 h after the last injection), the accumulation of Dopa during 30 min after inhibition of central aromatic amino acid decarboxylase by NSD 1015 (3-hydroxy-benzyl hydrazine, 150 mg/kg i.p.) was significantly increased in the noradrenaline (NA)-rich, but dopamine (DA)-poor, brain stem but not in the DA-rich, but NA-poor corpus striatum. An increased Dopa accumulation was also found in the limbic system and, probably, in the hemispheres. The central accumulation of 5-hydroxytryptophan (5-HTP) was significantly increased in the limbic system. Clonidine, 0.1 mg/kg i.p., administered to mice during the withdrawal phase caused reduction of the accumulation of Dopa and 5-HTP (during 30 min after NSD 1015, 150 mg/kg i.p.) in all brain regions studied to approximately the same levels, as when given to saline-pretreated controls. The disappearance rates of brain NA and DA after synthesis inhibition (α-methyl-p-tyrosine methylester HCl 250 mg/kg i.p., 4 h) were probably not altered by clonidine withdrawal.
The locomotor stimulation by the central catecholamine receptor agonists apomorphine plus clonidine (1.5 mg/kg i.p. both) after reserpine (10 mg/kg, 4 h) pretreatment was significantly enhanced in clonidine withdrawal mice. However, the motor stimulation by apomorphine (1.5 mg/kg i.p.) alone after reserpine pretreatment was not affected. The spontaneous motor activity was not significantly altered by the withdrawal of clonidine.
The data show that brain NA and 5-HT systems are affected by clonidine withdrawal in the opposite direction to that seen after acute administration of low doses of the drug, when they are inhibited. Since postsynaptic central α-adrenoceptors, which are stimulated by high but not by low doses of clonidine, showed an enhanced response to high doses of clonidine following discontinuation of a chronic low dose regimen, supersensitivity due to functional noradrenergic denervation might be implicated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andén, N.-E., Rubenson, A., Fuxe, K., Hökfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol. 19, 627–629 (1967)
Andén, N.-E., Corrodi, H., Fuxe, K.: Turnover studies using synthesis inhibition. In: Metabolism of amines in the brain (G. Hooper, ed.), pp. 38–47. London: Mac Millan 1969
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 9, 513–523 (1970)
Andén, N.-E., Strömbom, U., Svensson, T. H.: Dopamine and noradrenaline receptor stimulation: Reversal of reserpine-induced suppression of motor activity. Psychopharmacologia (Berl.) 29, 289–298 (1973)
Andén, N.-E., Grabowska, M., Strömbom, U.: Different α-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 43–52 (1976)
Atack, C. V.: The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay. Brit. J. Pharmacol. 48, 699–714 (1973)
Atack, C., Lindqvist, M.: Conjoint native and orthophthaldialdehyde-condensate assay for the fluorimetric determination of 5-hydroxyindoles in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 267–284 (1973)
Atack, C., Magnusson, T.: Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column by means of mineral acid-organic solvent mixtures. J. Pharm. Pharmacol. 22, 625–627 (1970)
Bertler, Å., Carlsson, A., Rosengren, E.: A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta physiol. scand. 44, 273–292 (1958)
Bolme, P., Corrodi, H., Fuxe, K., Hökfelt, T., Lidbrink, P., Goldstein, M.: Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine. Europ. J. Pharmacol. 28, 89–94 (1974)
Carlsson, A., Lindqvist, M.: Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo. J. Pharm. Pharmacol. 25, 437–440 (1973)
Carlsson, A., Davis, J. N., Kehr, W., Lindqvist, M., Atack, C.: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using a inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 153–168 (1972)
Cedarbaum, J. M., Aghajanian, G. K.: Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the α-antagonist piperoxane. Brain Res. 112, 413–419 (1976)
Davies, D. S., Reid, J. L.: Central action of drugs in blood pressure regulation. London: Pitman Publ. Ltd., Focal Press Ltd. 1975
Delbarre, B., Schmitt, H.: Sedative effects of α-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Europ. J. Pharmacol. 13, 356–363 (1971)
Delbarre, B., Schmitt, H.: Effects of clonidine and some α-adrenoreceptor blocking agents on avoidance conditional reflexes in rats: Their interactions and antagonism by atropine. Psychopharmacologia (Berl.) 35, 195–202 (1974)
Engström, G., Svensson, T. H., Waldeck, B.: Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity. Brain Res. 77, 471–483 (1974)
Ernst, A. M.: Mode of action of apomorphine and dexamphetamine on gnawing behaviour in rats. Psychopharmacologia (Berl.) 10, 316–323 (1967)
Farnebo, L.-O., Hamberger, B.: Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta physiol. scand., Suppl. 371, 35–44 (1971)
Fuxe, K., Hökfelt, T., Ungerstedt, U.: Morphological and functional aspects of central monoamine neurons. Int. Rev. Neurobiol. 13, 93–126 (1970)
Gallager, D. W., Aghajanian, G. K.: Effect of antipsychotic drugs on the firing of dorsal raphe cells. I. Role of adrenergic system. Europ. J. Pharmacol. 39, 341–355 (1976)
Haeusler, G.: Clonidine-induced inhibition of sympathetic nerve activity: No indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn-Schmiedeberg's Archt. Pharmacol. 286, 97–111 (1974)
Hansson, L., Hunyor, S. N., Julius, S., Hoobler, S. W.: Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Amer. Heart J. 85, 605–610 (1973)
Hökfelt, B., Hedeland, H., Dymling, J.-F.: Studies on catecholamines, renin and aldosterone following catapresan [2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride] in hypertensive patients. Europ. J. Pharmacol. 10, 389–397 (1970)
Hökfelt, T., Fuxe, K., Goldstein, M., Johansson, O.: Immunohistochemical evidence for the existence of adrenaline neurons in the rat brain. Brain Res. 66, 235–251 (1974)
Jouvet, M.: The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle. Rev. Physiol. 64, 166–307 (1972)
Kehr, W., Carlsson, A., Lindqvist, M.: A method for the determination of 3,4-dihydroxyphenylalanine (Dopa) in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 273–280 (1972)
Kobinger, W., Pichler, L.: The central modulatory effect of clonidine on the cardiodepressor reflex after suppression of synthesis and storage of noradrenaline. Europ. J. Pharmacol. 30, 56–62 (1975)
Starke, K., Montel, H.: Involvement of α-receptors in clonidineinduced inhibition of transmitter release from central monoamine neurones. Neuropharmacology 12, 1073–1080 (1973)
Strömbom, U.: Effects of low doses of catecholamine receptor agonists on exploration in mice. J. Neural Transmission 37, 229–235 (1975)
Strömbom, U.: Catecholamine receptor agonists: Effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 167–176 (1976)
Strömbom, U., Svensson, T. H., Jackson, D. M., Engström, G.: Hyperthyroidism: Specifically increased response to central Na-(α-)-receptor stimulation and generally increased monoamine turnover in brain. J. Neural Transmission. (In press, 1977)
Svensson, T. H., Bunney, B. S., Aghajanian, G. K.: Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res. 92, 291–306 (1975)
Winne, D.: Zur Auswertung von Versuchsergebnissen: Die Prüfung, ob Kurven sich in ihrem Verlauf unterscheiden. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 250, 383–306 (1965)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Svensson, T.H., Strömbom, U. Discontinuation of chronic clonidine treatment: Evidence for facilitated brain noradrenergic neurotransmission. Naunyn-Schmiedeberg's Arch. Pharmacol. 299, 83–87 (1977). https://doi.org/10.1007/BF00508642
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00508642